JPRN-UMIN000013890招募中2 期
AFTER trial - Aromatase inhibitor or fulvestrant after becoming to resistance of ethinylestradiol in postmenopausal women with metastatic breast cancer - prospective comparing trial
Department of Breast and Endocrine Surgery Graduate school of Medical Sciences, Kumamoto University0 个研究点目标入组 60 人开始时间: 2014年5月7日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. The case with active other malignancies 2. The case with HER2 positive tumor 3. The case with bilateral breast cancer 4. The case with inflammatory breast cancer 5. The case with past history of drug allergy or hypersensitivity 6. The case with severe progressive situation with non-indication ofr the hormone therapy 7. The case determined in appropriate by physicians
研究者
相似试验
已完成
不适用
A randomised trial of sequential aromatase inhibitors (AI) in postmenopausal women with locally advanced or metastatic breast cancerCancerBreast cancerISRCTN99515843International Collaborative Cancer Group (ICGG) (UK)
招募中
2 期
Investigation of the effect of letrozole in the treatment of ectopic pregnancies compared to methotrexate.IRCT20170828035961N2Esfahan University of Medical Sciences40
招募中
3 期
Effect of Aromatase inhibitors combination with oral contraceptive pills versus GnRH agonist on uterine myomaterine Myoma.Leiomyoma of uterusIRCT20140820018866N7Tehran University of Medical Sciences42
进行中（未招募）
1 期
PARAGON - Phase II study of aromatase inhibitors in women with potentially hormone responsive recurrent/metastatic gynaecological neoplasmsPatients with potentially hormone responsive recurrent or metastatic gynaecological cancers from following subgroups:A - Epithelial ovarian cancer, primary peritoneal cancers and cancers of the fallopian tubeB- Endometrial cancerC- Endometrial Stromal SarcomasD- Miscellaneous SarcomasE- Granulosa Cell Tumours and other Sex Tumours * UK sites will only enter patients to subgroups B-E *MedDRA version: 14.1Level: LLTClassification code 10026310Term: Malignant neoplasm of ovarySystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10014760Term: Endometrial neoplasm malignantSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-000501-52-GBGreater Glasgow and Clyde350
招募中
3 期
MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancerepithelial ovarian cancer2024-511219-78-00Swiss GO Trial Group300